Biotricity, Inc.BTCYNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank46
3Y CAGR-7.0%
5Y CAGR-40.2%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-7.0%/yr
vs -16.1%/yr prior
5Y CAGR
-40.2%/yr
Recent acceleration
Acceleration
+9.1pp
Accelerating
Percentile
P46
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 2.63% |
| Q3 2025 | 0.30% |
| Q2 2025 | 4.63% |
| Q1 2025 | 2.31% |
| Q4 2024 | 10.78% |
| Q3 2024 | 2.03% |
| Q2 2024 | 0.74% |
| Q1 2024 | 6.91% |
| Q4 2023 | 2.82% |
| Q3 2023 | -4.29% |
| Q2 2023 | 10.15% |
| Q1 2023 | 11.52% |
| Q4 2022 | 3.27% |
| Q3 2022 | 15.82% |
| Q2 2022 | -4.31% |
| Q1 2022 | 11.33% |
| Q4 2021 | 6.79% |
| Q3 2021 | 2.45% |
| Q2 2021 | 48.62% |
| Q1 2021 | 18.55% |
| Q4 2020 | 34.47% |
| Q3 2020 | 64.77% |
| Q2 2020 | 24.52% |
| Q1 2020 | -4.97% |
| Q4 2019 | 10.41% |
| Q3 2019 | 5.78% |
| Q2 2019 | 83.56% |
| Q1 2019 | 51.43% |
| Q4 2018 | 38.79% |
| Q3 2018 | 379.95% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |